Cargando…
Chemotherapy Resistance in Advanced Ovarian Cancer Patients
Ovarian cancer is the seventh most common gynaecologic malignancy seen in women. Majority of the patients with ovarian cancer are diagnosed at the advanced stage making prognosis poor. The standard management of advanced ovarian cancer includes tumour debulking surgery followed by chemotherapy. Vari...
Autores principales: | Pokhriyal, Ruchika, Hariprasad, Roopa, Kumar, Lalit, Hariprasad, Gururao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613062/ https://www.ncbi.nlm.nih.gov/pubmed/31308780 http://dx.doi.org/10.1177/1179299X19860815 |
Ejemplares similares
-
Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel
por: Sehrawat, Urmila, et al.
Publicado: (2016) -
Human Secretary Phospholipase A2 Mutations and Their Clinical Implications
por: Khan, Mohd Imran, et al.
Publicado: (2020) -
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Structural Modeling of Wild and Mutant Forms of Human Plasma Platelet Activating Factor-Acetyl Hydrolase Enzyme
por: Khan, Mohd Imran, et al.
Publicado: (2020)